You are at:Home»Popular Topics»Cancer Drug News»Protected: Novel triplet therapy for newly diagnosed multiple myeloma patients now PBS listed

Cancer Drug News

Protected: Novel triplet therapy for newly diagnosed multiple myeloma patients now PBS listed

By ONA Editor June 1, 2020 No Comments

About Author

ONA Editor

The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.

This post is password protected. Enter the password to view comments.

The Oncology Journal Club Episode 5: Cachexia, Gender Equity and Manels, Quick Bites, Special Guest Dr Christoper Steer and much more…

New class of precision medicine strips cancer of its DNA defences

The Oncology Journal Club Episode 5: Cachexia, Gender Equity and Manels, Quick Bites, Special Guest Dr Christoper Steer and much more…

New class of precision medicine strips cancer of its DNA defences

Protected: Novel triplet therapy for newly diagnosed multiple myeloma patients now PBS listed

About Author

The Oncology Journal Club Episode 5: Cachexia, Gender Equity and Manels, Quick Bites, Special Guest Dr Christoper Steer and much more…

New class of precision medicine strips cancer of its DNA defences

The Oncology Journal Club Episode 5: Cachexia, Gender Equity and Manels, Quick Bites, Special Guest Dr Christoper Steer and much more…

New class of precision medicine strips cancer of its DNA defences

About Author

Related Posts

Protected: Neoadjuvant treatment key to unlocking benefits of PBS-listed Kadcyla® (trastuzumab emtansine) in the adjuvant setting

Genetic test could pick out ‘ultra high risk’ bone marrow cancer patients

FDA approves new therapy for patients with previously treated multiple myeloma